Abstract
This paper presents the results of a cost-benefit analysis conducted for pregnancy prevention treatment with four hormonal methods of contraception using a managed-care viewpoint. The therapies analyzed are medroxy-progesterone acetate injection (Depo-Provera), levonorgestrel subdermal implants (Norplant), progestogenonly oral tablets (Nor-QD), and combination progestogen/estrogen oral tablets (Ortho-Novum 7/7/7). Cost and benefits associated with the use of therapies are identified and analyzed based on the cost per patient-day of effective pregnancy prevention. The analysis demonstrates that all four methods have a positive net benefit, with Depo-Provera having the highest net benefit. This information can provide decision makers within a pharmacy and therapeutics committee of a managed-care organization the framework on which to base formulary decisions.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Contraceptives, Oral, Combined / administration & dosage
-
Contraceptives, Oral, Combined / economics
-
Contraceptives, Oral, Combined / therapeutic use
-
Contraceptives, Oral, Synthetic / administration & dosage
-
Contraceptives, Oral, Synthetic / economics
-
Contraceptives, Oral, Synthetic / therapeutic use*
-
Cost-Benefit Analysis*
-
Drug Combinations
-
Ethinyl Estradiol / administration & dosage
-
Ethinyl Estradiol / economics
-
Ethinyl Estradiol / therapeutic use*
-
Fees, Medical
-
Female
-
Humans
-
Levonorgestrel / administration & dosage
-
Levonorgestrel / economics
-
Levonorgestrel / therapeutic use*
-
Medroxyprogesterone Acetate / administration & dosage
-
Medroxyprogesterone Acetate / economics
-
Medroxyprogesterone Acetate / therapeutic use*
-
Norethindrone / administration & dosage
-
Norethindrone / economics
-
Norethindrone / therapeutic use*
Substances
-
Contraceptives, Oral, Combined
-
Contraceptives, Oral, Synthetic
-
Drug Combinations
-
norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
-
Ethinyl Estradiol
-
Levonorgestrel
-
Medroxyprogesterone Acetate
-
Norethindrone